Submicron-size biodegradable polymer-based didanosine particles for treating HIV at early stage: an in vitro study

References

• Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008; 6: 388–400
   PubMed Web of Science ®Google Scholar
• Anderson J, Shive M. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Delivery Rev 1997; 28: 5–24
   PubMed Web of Science ®Google Scholar
• Barreiro P, Soriano V. Suboptimal CD4 gains in HIV-infected patients receiving didanosine plus tenofovir. J Antimicrob Chemother 2006; 57: 806–9
   PubMed Web of Science ®Google Scholar
• Bennewitz MF, Saltzman WM. Nanotechnology for the delivery of drugs to the brain for epilepsy. Neurotherapeutics 2009; 6: 323–36
   PubMed Web of Science ®Google Scholar
• Brobyn RD, 2012. The human toxicology of dimethyl sulfoxide. DMSO background literature [Online]. Available at: http://www.dmso.org/articles/information/brobyn.html. Accessed 24 January 2012
   Google Scholar
• Cunha-Filho MS, Martínez-Pacheco R, Landín M. Compatibility of the antitumoral beta-lapachone with different solid dosage forms excipients. J Pharm Biomed Anal 2007; 45: 590–8
   PubMedGoogle Scholar
• Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 2007; 177: 329–41
   PubMed Web of Science ®Google Scholar
• Gupta RB. Polymer or protein stabilized nanoparticles from emulsions. Nanoparticle technology for drug delivery. Drugs and the pharmaceutical sciences, RB Gupta, UB Compella. Taylor & Francis Group, Madison Avenue, New York 2006; 159: 85–102
   Google Scholar
• Higuchi T. Mechanism of sustained action medication: Theoretical analysis of rate of release of solid drug dispersed in solid matrices. J Pharm Sci 1963; 52: 1145–9
   PubMed Web of Science ®Google Scholar
• Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation (I) theoretical consideration. Ind Eng Chem 1931; 23: 923–31
   Google Scholar
• Kabanov AV, Vinogradov SV. Nanogels as pharmaceutical carriers: Finite networks of infinite capabilities. Angew Chem Int Ed Engl 2009; 48: 5418–29
   PubMed Web of Science ®Google Scholar
• Kashino G, Liu Y, Suzuki M, Masunaga SI, Kinashi Y, Ono K, Tano K, Watanabe M. An alternative mechanism for radioprotection by dimethyl sulfoxide; possible facilitation of DNA double-strand break repair. J Radiat Res 2010; 51: 733–40
   PubMed Web of Science ®Google Scholar
• Kasongo KW, Shegokar R, Muller RH, Walker RB. Formulation development and in vitro evaluation of didanosine-loaded nanostructured lipid carriers for the potential treatment of AIDS dementia complex. Drug Dev Ind Pharm 2011; 37: 396–407
   PubMed Web of Science ®Google Scholar
• Kaur A, Jain S, Tiwary AK. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: In vitro and in vivo evaluation. Acta Pharm 2008; 58: 61–74
   PubMed Web of Science ®Google Scholar
• Kim H, Cheng C, Kim Y, Chee Y. Preparation and hydrolytic degradation of semi-interpenetration networks of poly(3-hydroxyundecenoate) and poly(lactide-co-glycolide). Int J Biol Macromol 2005a; 37: 221–6
   PubMed Web of Science ®Google Scholar
• Kim D, Shall HE, Dennis D, Morey T. Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf B 2005b; 40: 83–91
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25–35
   Web of Science ®Google Scholar
• Kreuter J. Evaluation of nanoparticles as drug delivery systems, I. Preparation method. Pharm Acta Helv 1983; 58: 196–209
   Google Scholar
• Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X. PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Controlled Release 2001; 71: 203–11
   PubMed Web of Science ®Google Scholar
• Marques R, Williams A, Eksmond U, Wullaert A, Killeen N, Pasparakis M, Kioussis D, Kassiotis G. Generalized immune activation as a direct result of activated CD4+ T cell killing. J Biol 2009; 8: 93
   PubMedGoogle Scholar
• Mazzola L. Commercializing nanotechnology. Nat Biotechnol 2003; 21: 1137–43
   PubMed Web of Science ®Google Scholar
• Mehrgan H, Mortazavi SA. The release behavior and kinetic evaluation of diltiazem HCl from various hydrophilic and plastic based matrices. Iran J Pharm Res 2005; 3: 137–46
   Google Scholar
• Mukherjee B, Mahapatra S, Gupta R, Patra B, Tiwari A, Arora P. A comparison between povidone-ethylcellulose and povidone-eudragit transdermal dexamethasone matrix patches based on in vitro skin permeation. Eur J Pharm Biopharm 2005; 59: 475–83
   PubMed Web of Science ®Google Scholar
• Mukherjee B, Roy G, Santra K, Sahana B. Lactide-glycolide polymers as nanodimensional carriers for drugs. Int J Biomed Nanosci Nanotechnol 2010; 1: 230–46
   Google Scholar
• Murray CB, Kagan CR, Bawendi MG. Synthesis and characterization of monodisperse nanocrystals and close-packed nanocrystal assemblies. Annu Rev Mater Sci 2000; 30: 545–610
   Web of Science ®Google Scholar
• Parkin J, Shea C, Sant GR. Intravesical dimethyl sulfoxide (DMSO) interstitial cystitis: A practical approach. Urology 1997; 49: 105–7
   PubMed Web of Science ®Google Scholar
• Paull R, Wolfe J, Hebert P, Sinkula M. Investing in nanotechnology. Nat Biotechnol 2003; 21: 1144–7
   PubMed Web of Science ®Google Scholar
• Roy P, Das S, Bera T, Mondal S, Mukherjee A. Andrographolide nanoparticles in leishmaniasis: Characterization and in vitro evaluation. Int J Nanomed 2010; 5: 1113–21
   PubMed Web of Science ®Google Scholar
• Rubin LF. Toxicity of dimethyl sulfaoxide, alone and in combination. Ann N Y Acad Sci 1975; 243: 98–103
   PubMed Web of Science ®Google Scholar
• Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. Multidisciplinary utilization of dimethyl sulfoxide: Pharmacological, cellular and molecular aspects. Biochem Pharmacol 2003; 65: 1035–41
   PubMed Web of Science ®Google Scholar
• Schmid-Hempel P. Immune defence, parasite evasion strategies and their relevance for ‘macroscopic phenomena’ such as virulence. Philos Trans R Soc London Ser B 2008; 364: 85–98
   Google Scholar
• Siepmann J, Kranz H, Bodmeier R, Peppas NA. HPMA matrices for control drug delivery: A new model combining diffusion, swelling and dissolution mechanisms and predicting the release kinetics. Pharm Res 1999; 16: 1748–56
   PubMed Web of Science ®Google Scholar
• Skumiel A, Jozefczak A, Hornowski T. Investigation of magnetic and hyperthermic effects in ferrofluids with PEG biocompatible surfactant. J Phys Conf Ser 2009; 149: 012111, doi: 10.1088/1742-6596/149/1/012111
   Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Controlled Release 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Tobio M, Gref R, Sanchez A, Langer R, Alonso MJ. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm Res 1998; 15: 270–5
   PubMed Web of Science ®Google Scholar
• Tyagi P, Wu PC, Chancellor M, Yoshimura N, Huang L. Recent advances in intravesical drug/gene delivery. Mol Pharm 2006; 3: 369–79
   PubMed Web of Science ®Google Scholar
• Wang X, Wang Y, Chen Z, Shin DM. Advances of cancer therapy by nanotechnology. Cancer Res Treat 2009; 41: 1–11
   PubMed Web of Science ®Google Scholar
• Young J, Tang Z, Yu Q, Yu D, Wu Y. Selective killing of HIV-1-positive macrophages and T cells by the Rev-dependent lentivirus carrying anthrolysin O from Bacillus anthracis. Retrovirology 2008; 5: 36
   PubMed Web of Science ®Google Scholar
• Yue PF, Yuan HL, Yang M. Preparation, characterization, and pharmacokinetic evaluation of puerarin submicron emulsion. PDA J Pharm Sci Technol 2008; 62: 32–45
   PubMedGoogle Scholar